138 related articles for article (PubMed ID: 37625660)
1. Experts Achieve Consensus on a Majority of Statements Regarding Platelet-Rich Plasma Treatments for Treatment of Musculoskeletal Pathology.
Hurley ET; Sherman SL; Stokes DJ; Rodeo SA; Shapiro SA; Mautner K; Buford DA; Dragoo JL; Mandelbaum BR; Zaslav KR; Cole BJ; Frank RM;
Arthroscopy; 2024 Feb; 40(2):470-477.e1. PubMed ID: 37625660
[TBL] [Abstract][Full Text] [Related]
2. The use of injectable orthobiologics for knee osteoarthritis: A European ESSKA-ORBIT consensus. Part 1-Blood-derived products (platelet-rich plasma).
Laver L; Filardo G; Sanchez M; Magalon J; Tischer T; Abat F; Bastos R; Cugat R; Iosifidis M; Kocaoglu B; Kon E; Marinescu R; Ostojic M; Beaufils P; de Girolamo L;
Knee Surg Sports Traumatol Arthrosc; 2024 Apr; 32(4):783-797. PubMed ID: 38436492
[TBL] [Abstract][Full Text] [Related]
3. Minimum Information for Studies Evaluating Biologics in Orthopaedics (MIBO): Platelet-Rich Plasma and Mesenchymal Stem Cells.
Murray IR; Geeslin AG; Goudie EB; Petrigliano FA; LaPrade RF
J Bone Joint Surg Am; 2017 May; 99(10):809-819. PubMed ID: 28509821
[TBL] [Abstract][Full Text] [Related]
4. Even experts cannot agree on the optimal use of platelet-rich plasma in lateral elbow tendinopathy: an international Delphi study.
Evans JP; Maffulli N; Smith C; Watts A; Valderas J; Goodwin V
J Orthop Traumatol; 2021 Nov; 22(1):47. PubMed ID: 34825302
[TBL] [Abstract][Full Text] [Related]
5. Intra-articular injections of platelet-rich plasma in symptomatic knee osteoarthritis: a consensus statement from French-speaking experts.
Eymard F; Ornetti P; Maillet J; Noel É; Adam P; Legré-Boyer V; Boyer T; Allali F; Gremeaux V; Kaux JF; Louati K; Lamontagne M; Michel F; Richette P; Bard H;
Knee Surg Sports Traumatol Arthrosc; 2021 Oct; 29(10):3195-3210. PubMed ID: 32583023
[TBL] [Abstract][Full Text] [Related]
6. Editorial Commentary: Platelet-Rich Plasma for Musculoskeletal Conditions Is Supported by a Large Number of Clinical Studies, Particularly for Knee Osteoarthritis.
Hohmann E
Arthroscopy; 2024 Feb; 40(2):478-480. PubMed ID: 38296448
[TBL] [Abstract][Full Text] [Related]
7. Platelet-rich plasma (PRP) as therapy for cartilage, tendon and muscle damage - German working group position statement.
Tischer T; Bode G; Buhs M; Marquass B; Nehrer S; Vogt S; Zinser W; Angele P; Spahn G; Welsch GH; Niemeyer P; Madry H
J Exp Orthop; 2020 Sep; 7(1):64. PubMed ID: 32885339
[TBL] [Abstract][Full Text] [Related]
8. Autologous growth factor injections in chronic tendinopathy.
Sandrey MA
J Athl Train; 2014; 49(3):428-30. PubMed ID: 24840581
[TBL] [Abstract][Full Text] [Related]
9. Leukocyte concentration and composition in platelet-rich plasma (PRP) influences the growth factor and protease concentrations.
Kobayashi Y; Saita Y; Nishio H; Ikeda H; Takazawa Y; Nagao M; Takaku T; Komatsu N; Kaneko K
J Orthop Sci; 2016 Sep; 21(5):683-9. PubMed ID: 27503185
[TBL] [Abstract][Full Text] [Related]
10. The Cost Variability of Orthobiologics.
Momaya AM; McGee AS; Dombrowsky AR; Wild AJ; Faroqui NM; Waldrop RP; He JK; Brabston EW; Ponce BA
Sports Health; 2020; 12(1):94-98. PubMed ID: 31665613
[TBL] [Abstract][Full Text] [Related]
11. Conservative Management and Biological Treatment Strategies: Proceedings of the International Consensus Meeting on Cartilage Repair of the Ankle.
Dombrowski ME; Yasui Y; Murawski CD; Fortier LA; Giza E; Haleem AM; Hamid K; Tuan R; Zhang Z; Schon LC; Hogan MV;
Foot Ankle Int; 2018 Jul; 39(1_suppl):9S-15S. PubMed ID: 30215314
[TBL] [Abstract][Full Text] [Related]
12. Utilization of Orthobiologics by Sports Medicine Physicians: A Survey-based Study.
Noback PC; Donnelley CA; Yeatts NC; Parisien RL; Fleischli JE; Ahmad CS; Moorman CT; Trofa DP; Saltzman BM
J Am Acad Orthop Surg Glob Res Rev; 2021 Jan; 5(1):e20.00185. PubMed ID: 33410651
[TBL] [Abstract][Full Text] [Related]
13. Platelet-rich plasma treatment for ligament and tendon injuries.
Paoloni J; De Vos RJ; Hamilton B; Murrell GA; Orchard J
Clin J Sport Med; 2011 Jan; 21(1):37-45. PubMed ID: 21200169
[TBL] [Abstract][Full Text] [Related]
14. The Role of Platelet-Rich Plasma in Cartilage Pathology: An Updated Systematic Review of the Basic Science Evidence.
Fice MP; Miller JC; Christian R; Hannon CP; Smyth N; Murawski CD; Cole BJ; Kennedy JG
Arthroscopy; 2019 Mar; 35(3):961-976.e3. PubMed ID: 30733026
[TBL] [Abstract][Full Text] [Related]
15. A double blind randomised control trial investigating the efficacy of platelet rich plasma versus placebo for the treatment of greater trochanteric pain syndrome (the HIPPO trial): a protocol for a randomised clinical trial.
Oderuth E; Ali M; Atchia I; Malviya A
Trials; 2018 Sep; 19(1):517. PubMed ID: 30241561
[TBL] [Abstract][Full Text] [Related]
16. Platelet-Rich Plasma for Patellar Tendinopathy: A Randomized Controlled Trial of Leukocyte-Rich PRP or Leukocyte-Poor PRP Versus Saline.
Scott A; LaPrade RF; Harmon KG; Filardo G; Kon E; Della Villa S; Bahr R; Moksnes H; Torgalsen T; Lee J; Dragoo JL; Engebretsen L
Am J Sports Med; 2019 Jun; 47(7):1654-1661. PubMed ID: 31038979
[TBL] [Abstract][Full Text] [Related]
17. Clinical indications for image-guided interventional procedures in the musculoskeletal system: a Delphi-based consensus paper from the European Society of Musculoskeletal Radiology (ESSR)-Part II, elbow and wrist.
Sconfienza LM; Adriaensen M; Albano D; Aparisi Gómez MP; Bazzocchi A; Beggs I; Bignotti B; Chianca V; Corazza A; Dalili D; De Dea M; Del Cura JL; Di Pietto F; Drakonaki E; Facal de Castro F; Filippiadis D; Gielen J; Gitto S; Gupta H; Klauser AS; Lalam R; Martin S; Martinoli C; Mauri G; McCarthy C; McNally E; Melaki K; Messina C; Mirón Mombiela R; Neubauer B; Obradov M; Olchowy C; Orlandi D; Plagou A; Prada Gonzalez R; Rutkauskas S; Snoj Z; Tagliafico AS; Talaska A; Vasilevska-Nikodinovska V; Vucetic J; Wilson D; Zaottini F; Zappia M; Allen G;
Eur Radiol; 2020 Apr; 30(4):2220-2230. PubMed ID: 31844963
[TBL] [Abstract][Full Text] [Related]
18. Defining Platelet-Rich Plasma Usage by Team Physicians in Elite Athletes.
Kantrowitz DE; Padaki AS; Ahmad CS; Lynch TS
Orthop J Sports Med; 2018 Apr; 6(4):2325967118767077. PubMed ID: 29780836
[TBL] [Abstract][Full Text] [Related]
19. The effectiveness of leucocyte-poor platelet-rich plasma injections on symptomatic early osteoarthritis of the knee: the PEAK randomized controlled trial.
Lewis E; Merghani K; Robertson I; Mulford J; Prentice B; Mathew R; Van Winden P; Ogden K
Bone Joint J; 2022 Jun; 104-B(6):663-671. PubMed ID: 35638203
[TBL] [Abstract][Full Text] [Related]
20. Current Trends in Orthobiologics: An 11-Year Review of the Orthopaedic Literature.
Obana KK; Schallmo MS; Hong IS; Ahmad CS; Moorman CT; Trofa DP; Saltzman BM
Am J Sports Med; 2022 Sep; 50(11):3121-3129. PubMed ID: 34528456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
